PRESS RELEASE published on 12/28/2023 at 14:10, 2 years 1 month ago NeoGenomics to Appeal Ruling NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
PRESS RELEASE published on 12/05/2023 at 14:00, 2 years 2 months ago NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
PRESS RELEASE published on 11/14/2023 at 13:00, 2 years 3 months ago NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
PRESS RELEASE published on 11/06/2023 at 22:05, 2 years 3 months ago NeoGenomics Reports Third Quarter 2023 Results
PRESS RELEASE published on 10/24/2023 at 13:00, 2 years 3 months ago NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
PRESS RELEASE published on 10/17/2023 at 15:20, 2 years 4 months ago NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
Published on 02/18/2026 at 19:10, 1 hour 35 minutes ago Secure Blockchain Announces Definitive Agreement to Acquire Agentic Solutions Limited, Private Placement and Debt Settlement
Published on 02/18/2026 at 15:15, 5 hours 30 minutes ago Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 5 hours 45 minutes ago Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 6 hours 20 minutes ago Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 6 hours 45 minutes ago Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 19:11, 1 hour 34 minutes ago flatexDEGIRO adopts new capital allocation policy – increase in annual dividend by a factor of seven planned; 2025 guidance slightly exceeded
Published on 02/18/2026 at 18:54, 1 hour 51 minutes ago EQS-Adhoc: flatexDEGIRO SE: Management and Supervisory Board adopt new capital allocation policy; dividend increase to 20% of Net Income targeted; FY 2025 guidance slightly exceeded
Published on 02/18/2026 at 18:21, 2 hours 23 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/18/2026 at 18:00, 2 hours 45 minutes ago E-PANGO : Décision du Tribunal administratif de Paris en date du 16 février 2026
Published on 02/18/2026 at 18:00, 2 hours 45 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 janvier 2026
Published on 02/18/2026 at 18:00, 2 hours 45 minutes ago Outstanding Shares and Voting Rights Statement at 31 January 2026
Published on 02/18/2026 at 17:40, 3 hours 5 minutes ago GROUPE ES - Communiqué sur les résultats 2025
Published on 02/18/2026 at 13:45, 7 hours ago NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède